PM Lee: Singapore invest heavily in R&D; builds Covid-19 vaccine manufacturing capacity (update)


SINGAPORE: Singapore Prime Minister Lee Hsien Loong (pic) said on Friday (June 5) the republic is investing heavily in the research and development (R&D) on Covid-19 (coronavirus) diagnostics, vaccines and therapeutics while at the same time building up its vaccine manufacturing capacity.

"Our researchers have developed a range of serological and nucleic acid based diagnostic tests, which have been deployed to over 20 countries,” Lee told the Global Vaccine Summit which was co-hosted by the UK government and Gavi, the Vaccine Alliance, via a video call.

Subscribe now and receive FREE sooka plan for 1 month.
T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Aseanplus News

Hunter’s Moon: 2024’s brightest and closest supermoon
Alpha IVF Group expands into Indonesia with new satellite clinic in Jakarta
Budget 2025 to drive economic growth, ensure fairness for all, says Anwar
Vietnam tycoon Truong My Lan gets life term; already has death sentence from separate trial
Sabah Law Society wins leave to pursue state’s 40% constitutional entitlement review
Najib denies creating ‘Advisor Emeritus’ post in SRC International to tighten his control of the company
Wise becomes first foreign firm to gain direct access to Japan's payment clearing network
Parliament amends Constitution to grant automatic citizenship to kids born abroad to Malaysian mothers
China says it 'expelled' Japanese ship from waters near disputed islands
Indonesia secures release of 12 citizens trapped in Myanmar online scam

Others Also Read